Literature DB >> 23999990

The diverse role of miR-31 in regulating cancer associated phenotypes.

Eeva M Laurila1, Anne Kallioniemi.   

Abstract

In the past 10 years research on miRNAs has demonstrated their central role in regulating gene expression both in normal and diseased tissue. The expression of miRNAs is widely altered in cancer, leading to abnormal expression of the genes regulated by these miRNAs, and subsequently alterations in entire molecular networks and pathways. One especially interesting cancer-related miRNA is miR-31 which is frequently altered in a large variety of cancers. The functional role of miR-31 is extremely complex and miR-31 can hold both tumor suppressive and oncogenic roles in different tumor types. The phenotype caused by aberrant miR-31 expression seems to be strongly dependent on the endogenous expression levels. For example, in breast cancer loss of miR-31 expression is associated with high risk of metastases, whereas in colorectal cancer high miR-31 expression correlates with advanced disease stage. This review summarizes the complex expression patterns of miR-31 in human cancers, describes the variable phenotypes caused by altered miR-31 expression, and highlights the current knowledge on the genes targeted by miR-31.
Copyright © 2013 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23999990     DOI: 10.1002/gcc.22107

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  44 in total

1.  The Cancer Genome Atlas Analysis Predicts MicroRNA for Targeting Cancer Growth and Vascularization in Glioblastoma.

Authors:  Hon-Kit Andus Wong; Rachid El Fatimy; Courtney Onodera; Zhiyun Wei; Ming Yi; Athul Mohan; Sindhuja Gowrisankaran; Priya Karmali; Eric Marcusson; Hiroaki Wakimoto; Robert Stephens; Erik J Uhlmann; Jun S Song; Bakhos Tannous; Anna M Krichevsky
Journal:  Mol Ther       Date:  2015-04-23       Impact factor: 11.454

2.  MicroRNA-31 initiates lung tumorigenesis and promotes mutant KRAS-driven lung cancer.

Authors:  Mick D Edmonds; Kelli L Boyd; Tamara Moyo; Ramkrishna Mitra; Robert Duszynski; Maria Pia Arrate; Xi Chen; Zhongming Zhao; Timothy S Blackwell; Thomas Andl; Christine M Eischen
Journal:  J Clin Invest       Date:  2015-12-14       Impact factor: 14.808

Review 3.  Function and regulation of microRNA-31 in development and disease.

Authors:  Nadezda A Stepicheva; Jia L Song
Journal:  Mol Reprod Dev       Date:  2016-08-02       Impact factor: 2.609

4.  miRNA Expression Change in Dorsal Root Ganglia After Peripheral Nerve Injury.

Authors:  Hsueh-Ling Chang; Hung-Chen Wang; Yi-Ta Chunag; Chao-Wen Chou; I-Ling Lin; Chung-Sheng Lai; Lin-Li Chang; Kuang-I Cheng
Journal:  J Mol Neurosci       Date:  2016-12-24       Impact factor: 3.444

5.  MicroRNA-31 is a transcriptional target of histone deacetylase inhibitors and a regulator of cellular senescence.

Authors:  Joon-Ho Cho; Manjari Dimri; Goberdhan P Dimri
Journal:  J Biol Chem       Date:  2015-03-03       Impact factor: 5.157

6.  Unique microRNA alterations in hepatocellular carcinomas arising either spontaneously or due to chronic exposure to Ginkgo biloba extract (GBE) in B6C3F1/N mice.

Authors:  Haruhiro Yamashita; Sailesh Surapureddi; Ramesh C Kovi; Sachin Bhusari; Thai Vu Ton; Jian-Liang Li; Keith R Shockley; Shyamal D Peddada; Kevin E Gerrish; Cynthia V Rider; Mark J Hoenerhoff; Robert C Sills; Arun R Pandiri
Journal:  Arch Toxicol       Date:  2020-04-18       Impact factor: 5.153

7.  Engagement of circular RNA HECW2 in the nonautophagic role of ATG5 implicated in the endothelial-mesenchymal transition.

Authors:  Li Yang; Bing Han; Yuan Zhang; Ying Bai; Jie Chao; Gang Hu; Honghong Yao
Journal:  Autophagy       Date:  2018-01-29       Impact factor: 16.016

Review 8.  MicroRNA in rectal cancer.

Authors:  Azadeh Azizian; Jens Gruber; B Michael Ghadimi; Jochen Gaedcke
Journal:  World J Gastrointest Oncol       Date:  2016-05-15

9.  Repression of Esophageal Neoplasia and Inflammatory Signaling by Anti-miR-31 Delivery In Vivo.

Authors:  Cristian Taccioli; Michela Garofalo; Hongping Chen; Yubao Jiang; Guidantonio Malagoli Tagliazucchi; Gianpiero Di Leva; Hansjuerg Alder; Paolo Fadda; Justin Middleton; Karl J Smalley; Tommaso Selmi; Srivatsava Naidu; John L Farber; Carlo M Croce; Louise Y Fong
Journal:  J Natl Cancer Inst       Date:  2015-08-18       Impact factor: 13.506

10.  miR-31 and miR-17-5p levels change during transformation of follicular lymphoma.

Authors:  Mary Ann Thompson; Mick D Edmonds; Shan Liang; Sara McClintock-Treep; Xuan Wang; Shaoying Li; Christine M Eischen
Journal:  Hum Pathol       Date:  2015-11-30       Impact factor: 3.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.